FAQ:What benefits leaders need to know about fertility mandates

For most large employers, the answer is no.
‍
State mandates apply to fully insured plans — where you buy coverage from 
an insurance carrier that is regulated by your state. If your plan is self-insured, federal ERISA law governs it instead, and ERISA generally preempts state insurance regulations.
‍
In practice, this means a self-insured employer headquartered in California or New York is not legally required to cover IVF. That said, fully insured competitors in those states are required to offer it — which has real implications for how your benefits package compares. Most large employers are self-insured, so this distinction affects the majority of enterprise benefits leaders.

There are several active proposals, but nothing has passed into law yet. 
Here's the current status of the three most significant federal developments:

• Trump Executive Order (signed February 2025): This order directed federal agencies to develop proposals for protecting IVF access and reducing out-of-pocket costs. This has already influenced how the administration talks about fertility care — as a medical necessity rather than an elective procedure. Regulatory guidance stemming from this order is still being developed.
  
• The Protect IVF Act (S.2035, introduced June 2025): This would give providers the legal right to offer fertility treatment, patients the right to receive it, and insurers the right to cover it — without interference. This is currently sitting in the Senate HELP Committee, but has not advanced to a floor vote.
• The Health Coverage for IVF Act (H.R.3480, introduced May 2025): This would add fertility treatment to the ACA's list of essential health benefits, effectively requiring all ACA-compliant plans to cover it nationwide — including individual and small group markets that state mandates don't currently reach. This is also in committee with no vote currently scheduled.

A complete fertility benefit covers diagnostics (bloodwork, hormone panels, semen analysis), medications, IVF procedures, genetic testing (PGT), embryo transfers, and cryopreservation and storage. It should also include fertility preservation for employees undergoing cancer treatment, plus care navigation and mental health support — both of which meaningfully improve clinical outcomes and engagement.
‍
Plans that cover procedures but not medications, or cycles but not storage, leave employees absorbing the difference out of pocket — and often delay or abandon treatment as a result.
‍
Maven covers all of this within a single managed benefit. More than 40% of Maven fertility members access mental health coaching during treatment, and Care Advocates are available within an hour on average to help members navigate next steps, find in-network providers, and stay on track.

Fully insured means you buy coverage from an insurance carrier, which assumes the financial risk and must comply with state law — including fertility mandates.
‍
Self-insured means your company funds claims directly, typically with stop-loss protection. These plans are governed by federal ERISA law, which means state mandates generally don't apply.
‍
For example, a self-insured employer in New York, Massachusetts, or Colorado — three states with some of the most comprehensive IVF mandates in the country — has no legal obligation to cover IVF, but their fully insured competitors do.

Four decisions shape most of the cost and outcome variation in fertility benefits:

• Cycle caps vs. dollar limits [cycle caps limit the number of treatment rounds covered; dollar limits set a maximum spend]: Cycle caps are easier for members to plan around. Dollar limits can run out mid-treatment without warning.
  
• Step therapy [a protocol requiring employees to try less intensive treatments before IVF is authorized]: Requiring IUI before IVF authorization sounds like a cost-saver, but poorly designed protocols often delay effective treatment and increase total spend.
• Centers of Excellence [a network of credentialed fertility clinics selected for quality, outcomes, and cost-effectiveness]: Directing members to credentialed clinics with strong outcome data is one of the most effective ways to manage cost and improve results.
• Inclusive eligibility [the criteria determining who qualifies for fertility benefits under your plan]: Benefits that require a formal infertility diagnosis or restrict access based on relationship status or sexual orientation are increasingly out of step with both workforce demographics and state law.

What's commonly required: infertility diagnosis, IUI, IVF procedures, and fertility preservation for cancer patients. What's frequently excluded: preimplantation genetic testing, donor eggs or sperm, embryo storage beyond a short initial window, and surrogacy-related costs.
‍
Access for LGBTQ+ individuals and single employees also varies significantly by state. Older mandates often required a heterosexual couple with a documented infertility diagnosis. Newer laws — including California's SB 729 — explicitly extend coverage regardless of sex, relationship status, or prior diagnosis.

Yes — and the primary driver is employee health outcomes. Without employer coverage, employees in non-mandate states are more likely to delay or forgo treatment, attempt riskier protocols to reduce costs, or transfer multiple embryos to avoid paying for additional cycles — all of which increase the likelihood of complications, high-risk pregnancies, and NICU admissions.
‍
Unmanaged fertility care is expensive care. Nationally, IVF miscarriage rates run 18–30%, according to the SART National Summary Report, and 12.5% of IVF births result in multiples, according to the CDC National ART Surveillance — a key driver of NICU admissions and employer cost. In contrast, Maven members experience an 11% miscarriage rate, a 98% singleton rate, and a 1.8% multiples rate. And 30% of Maven fertility members never need IVF or IUI at all. Those outcomes are the direct result of clinical governance and early intervention, not geography.

Clinical management, not benefit restriction. Cutting cycles or adding barriers reduces access but doesn't address what actually drives cost: unmanaged utilization, preventable complications, and treatment that starts too late. 
‍
Most fertility cost problems aren't a coverage problem — they're a management problem. The most effective approach combines three things: Centers of Excellence to reduce unnecessary interventions and drive better clinical outcomes; evidence-based protocols that limit add-ons that increase cost without improving results; and preconception support, which is where the biggest cost avoidance happens. 30% of Maven fertility members achieve pregnancy without IVF or IUI at all, and members who participate in fertility coaching are 55% more likely to conceive without treatment. Every member who conceives without a procedure is a cycle that was never needed.

A point solution covers fertility procedures like IVF — and stops there. An integrated benefit covers the full journey: preconception coaching, fertility treatment, pregnancy support, and postpartum care within a single clinical model.
‍
The difference shows up directly in cost. Maven saves employers $9,600 per birth — a result of intervening early and maintaining continuity of care from preconception through postpartum. That figure isn't achievable when the benefit ends at egg retrieval.